在线报刊亭
Anti-Obesity Drugs Market, 2016 - 2022 1 点击阅读
  • 评论

Anti-Obesity Drugs Market, 2016 - 2022

1

出版日期 / “科学, 科学” / 语言—English / 4页
Global anti-obesity drugs market segmented by approved drugs: buproprion and naltrexone (Contrave), orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), and liraglutide (Saxenda). 更多
免费订阅

相关的杂志